Abstract
Stable cell lines that express a gene of specific interest provide an advantage over transient gene expression by reducing variations in transfection efficiency between experiments, sustaining expression for long-term studies, and controlling expression levels in particular if a clonal population is selected. Transient transfection requires introduction of an exogenous gene into host cells via typically harsh chemicals or conditions that permeabilize the cell membrane, which does not normally integrate into the target cell genome. Here, we describe the method of using retroviral transduction to stably express Golgi proteins fused to a promiscuous biotin ligase (TurboID) in HeLa cells, thus creating cell lines that can be leveraged in studies of the proximome/interactome. We also demonstrate a similar protocol for stable expression of a Golgi protein fused to a fluorescent tag via lentiviral transduction. These methods can be further adapted to establish other cell lines with different sub-cellular markers or fusion tags. Viral transduction is a convenient method to create stable cell lines in cell-based studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wang D, Tai P, Gao G (2019) Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov 18(5). https://doi.org/10.1038/s41573-019-0012-9
Milone MC, O’Doherty U (2018) Clinical use of lentiviral vectors. Leukemia 32(7):1529–1541. https://doi.org/10.1038/s41375-018-0106-0
Bekier M, Wang L, Li J, Huang H, Tang D, Zhang X, Wang Y (2017) Knockout of the Golgi stacking proteins GRASP55 and GRASP65 impairs Golgi structure and function. Mol Biol Cell 28(21). https://doi.org/10.1091/mbc.E17-02-0112
Hindmarsh P, Leis J (1999) Retroviral DNA integration. Microbiol Mol Biol Rev 63(4). https://doi.org/10.1128/MMBR.63.4.836-843.1999
Bouard D, Alazard-Dany D, Cosset F (2009) Viral vectors: from virology to transgene expression. Br J Pharmacol 157(2). https://doi.org/10.1038/bjp.2008.349
Joglekar A, Sandoval S (2017) Pseudotyped lentiviral vectors: one vector, many guises. Hum Gene Ther Methods 28(6). https://doi.org/10.1089/hgtb.2017.084
Balvay L, Lopez LM, Sargueil B, Darlix J, Ohlmann T (2007) Translational control of retroviruses. Nat Rev Microbiol 5(2). https://doi.org/10.1038/nrmicro1599
Bekier ME 2nd, Wang L, Li J, Huang H, Tang D, Zhang X, Wang Y (2017) Knockout of the Golgi stacking proteins GRASP55 and GRASP65 impairs Golgi structure and function. Mol Biol Cell 28(21):2833–2842. https://doi.org/10.1091/mbc.E17-02-0112
Davis H, Morgan J, Yarmush M (2002) Polybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranes. Biophys Chem 97(2–3). https://doi.org/10.1016/s0301-4622(02)00057-1
Moore J, Trkola A, Dragic T (1997) Co-receptors for HIV-1 entry. Curr Opin Immunol 9(4). https://doi.org/10.1016/s0952-7915(97)80110-0
Kafri T, Blömer U, Peterson D, Gage F, Verma I (1997) Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 17(3). https://doi.org/10.1038/ng1197-314
Peng K, Pham L, Ye H, Zufferey R, Trono D, Cosset F, Russell S (2001) Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors. Gene Ther 8(19). https://doi.org/10.1038/sj.gt.3301552
Sakuma T, De Ravin S, Tonne J, Thatava T, Ohmine S, Takeuchi Y, Malech H, Ikeda Y (2010) Characterization of retroviral and lentiviral vectors pseudotyped with xenotropic murine leukemia virus-related virus envelope glycoprotein. Hum Gene Ther 21(12). https://doi.org/10.1089/hum.2010.063
Diaz R, Bateman A, Emiliusen L, Fielding A, Trono D, Russell S, Vile R (2000) A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy. Gene Ther 7(19). https://doi.org/10.1038/sj.gt.3301277
Jang J, Shaw K, Yu X, Petersen D, Pepper K, Lutzko C, Kohn D (2006) Specific and stable gene transfer to human embryonic stem cells using pseudotyped lentiviral vectors. Stem Cells Dev 15(1). https://doi.org/10.1089/scd.2006.15.109
Bell A, Fegen D, Ward M, Bank A (2010) RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors. Exp Biol Med (Maywood, NJ) 235(10). https://doi.org/10.1258/ebm.2010.010053
Hale C, Majumdar S, Elmore J, Pfister N, Compton M, Olson S, Resch A, Glover C, Graveley B, Terns R, Terns M (2012) Essential features and rational design of CRISPR RNAs that function with the Cas RAMP module complex to cleave RNAs. Mol Cell 45(3). https://doi.org/10.1016/j.molcel.2011.10.023
Schambach A, Galla M, Modlich U, Will E, Chandra S, Reeves L, Colbert M, Williams D, von Kalle C, Baum C (2006) Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical research. Exp Hematol 34(5). https://doi.org/10.1016/j.exphem.2006.02.005
Hanawa H, Kelly P, Nathwani A, Persons D, Vandergriff J, Hargrove P, Vanin E, Nienhuis A (2002) Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Mol Ther 5(3). https://doi.org/10.1006/mthe.2002.0549
Janssens W, Chuah M, Naldini L, Follenzi A, Collen D, Saint-Remy J, VandenDriessche T (2003) Efficiency of onco-retroviral and lentiviral gene transfer into primary mouse and human B-lymphocytes is pseudotype dependent. Hum Gene Ther 14(3). https://doi.org/10.1089/10430340360535814
Levy C, Fusil F, Amirache F, Costa C, Girard-Gagnepain A, Negre D, Bernadin O, Garaulet G, Rodriguez A, Nair N, Vandendriessche T, Chuah M, Cosset F, Verhoeyen E (2016) Baboon envelope pseudotyped lentiviral vectors efficiently transduce human B cells and allow active factor IX B cell secretion in vivo in NOD/SCIDγc −/− mice. J Thromb Haemost 14(12). https://doi.org/10.1111/jth.13520
Uhlig KM, Schülke S, Scheuplein VAM, Malczyk AH, Reusch J, Kugelmann S, Muth A, Koch V, Hutzler S, Bodmer BS, Schambach A, Buchholz CJ, Waibler Z, Scheurer S, Mühlebach MD, Kirchhoff F (2015) Lentiviral protein transfer vectors are an efficient vaccine platform and induce a strong antigen-specific xytotoxic T cell response. J Virol 89(17):9044–9060. https://doi.org/10.1128/JVI.00844-15
Zhou Q, Schneider I, Gallet M, Kneissl S, Buchholz C (2011) Resting lymphocyte transduction with measles virus glycoprotein pseudotyped lentiviral vectors relies on CD46 and SLAM. Virology 413(2). https://doi.org/10.1016/j.virol.2011.02.010
Witting SR, Vallanda P, Gamble AL (2013) Characterization of a third generation lentiviral vector pseudotyped with Nipah virus envelope proteins for endothelial cell transduction. Gene Therapy 20(10):997–1005. https://doi.org/10.1038/gt.2013.23
Palomares K, Vigant F, Handel BV, Pernet O, Chikere K, Hong P, Sherman SP, Patterson M, An DS, Lowry WE, Mikkola HKA, Morizono K, Pyle AD, Lee B (2013) Nipah virus envelope-pseudotyped lentiviruses efficiently target ephrinB2-positive stem cell populations in vitro and bypass the liver sink when administered in vivo. J Virol 87(4):2094–2108. https://doi.org/10.1128/JVI.02032-12
Carpentier DCJ, Vevis K, Trabalza A, Georgiadis C, Ellison SM, Asfahani RI, Mazarakis ND (2011) Enhanced pseudotyping efficiency of HIV-1 lentiviral vectors by a rabies/vesicular stomatitis virus chimeric envelope glycoprotein. Gene Therapy 19(7):761–774. https://doi.org/10.1038/gt.2011.124
Cronin J, Zhang X, Reiser J (2005) Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 5(4). https://doi.org/10.2174/1566523054546224
Kato S, Kobayashi K, Kobayashi K (2014) Improved transduction efficiency of a lentiviral vector for neuron-specific retrograde gene transfer by optimizing the junction of fusion envelope glycoprotein, J Neurosci Methods 227. https://doi.org/10.1016/j.jneumeth.2014.02.015
Hachiya A, Sriwiriyanont P, Patel A, Saito N, Ohuchi A, Kitahara T, Takema Y, Tsuboi R, Boissy RE, Visscher MO, James WM, Kobinger GP (2007) Gene transfer in human skin with different pseudotyped HIV-based vectors. Gene Ther 14(8):648–656. https://doi.org/10.1038/sj.gt.3302915
Colin A, Faideau M, Dufour N, Auregan G, Hassig R, Andrieu T, Brouillet E, Hantraye P, Bonvento G, Déglon N (2009) Engineered lentiviral vector targeting astrocytes in vivo. Glia 57(6). https://doi.org/10.1002/glia.20795
Sinn P, Coffin J, Ayithan N, Holt K, Maury W (2017) Lentiviral Vectors Pseudotyped with Filoviral Glycoproteins. Methods in molecular biology (Clifton, NJ) 1628. https://doi.org/10.1007/978-1-4939-7116-9_5
Dylla DE, Xie L, Michele DE, Kunz S, McCray PB (2011) Altering α-dystroglycan receptor affinity of LCMV pseudotyped lentivirus yields unique cell and tissue tropism. Genet Vaccines Ther 9(1):1–13. https://doi.org/10.1186/1479-0556-9-8
Kumar M, Bradow BP, Zimmerberg J (2004) Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64. https://home.liebertpub.com/hum. https://doi.org/10.1089/10430340360464723
Kahl CA, Marsh J, Fyffe J, Sanders DA, Cornetta K (2004) Human immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virus. J Virol 78(3):1421–1430. https://doi.org/10.1128/JVI.78.3.1421-1430.2004
Salvador B, Zhou Y, Michault A, Muench M, Simmons G (2009) Characterization of Chikungunya pseudotyped viruses: identification of refractory cell lines and demonstration of cellular tropism differences mediated by mutations in E1 glycoprotein. Virology 393(1). https://doi.org/10.1016/j.virol.2009.07.013
Kang Y, Stein C, Heth J, Sinn P, Penisten A, Staber P, Ratliff K, Shen H, Barker C, Martins I, Sharkey C, Sanders D, McCray P, Davidson B (2002) In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins. J Virol 76(18). https://doi.org/10.1128/jvi.76.18.9378-9388.2002
Poluri A, Ainsworth R, Weaver SC, Sutton RE (2008) Functional pseudotyping of human immunodeficiency virus type 1 vectors by western equine encephalitis virus envelope glycoprotein. https://doi.org/10.1128/JVI.01503-08
McKay T, Patel M, Pickles RJ, Johnson LG, Olsen JC (2006) Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors. Gene Ther 13(8):715–724. https://doi.org/10.1038/sj.gt.3302715
Patel M, Giddings A, Sechelski J, Olsen J (2013) High efficiency gene transfer to airways of mice using influenza hemagglutinin pseudotyped lentiviral vectors. J Gene Med 15(1). https://doi.org/10.1002/jgm.2695
Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci U S A 90(17):8033–8037. https://doi.org/10.1073/pnas.90.17.8033
Wong L, Azzouz M, Walmsley L, Askham Z, Wilkes F, Mitrophanous K, Kingsman S, Mazarakis N (2004) Transduction patterns of pseudotyped lentiviral vectors in the nervous system. Mol Ther 9(1). https://doi.org/10.1016/j.ymthe.2003.09.017
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Bui, S., Li, J., Stark, D., Houmani, A., Wang, Y. (2023). Generation of Stable Cell Lines Expressing Golgi Reassembly Stacking Proteins (GRASPs) by Viral Transduction. In: Wang, Y., Lupashin, V.V., Graham, T.R. (eds) Golgi. Methods in Molecular Biology, vol 2557. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2639-9_24
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2639-9_24
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2638-2
Online ISBN: 978-1-0716-2639-9
eBook Packages: Springer Protocols